PET/CT Scans Should Follow EANM Guidelines for Optimal Clinical Results
PET/CT scans should follow the European Association of Nuclear Medicine (EANM) procedure guidelines for tumor imaging to ensure standardized, high-quality imaging with optimal diagnostic value. 1
EANM Guidelines for PET/CT Acquisition
Patient Preparation
- Patient preparation aims to reduce tracer uptake in normal tissues while optimizing uptake in target structures and keeping radiation exposure as low as reasonably achievable (ALARA) 1
- Complete medical history review should focus on tumor type, known tumor sites, oncological history, and relevant comorbidities (especially infection/inflammation and diabetes mellitus) 1
- Patient height and weight must be measured directly before each examination, particularly for standardized uptake value (SUV) measurements 1
CT Protocol Components
- PET/CT examinations typically include a topogram/scout scan followed by CT scan(s) 1
- CT acquisition parameters (tube current, voltage, slice thickness, rotation time, pitch) should be selected based on the examination objective 1
- Two main CT options are available within PET/CT studies:
CT Acquisition Techniques
- The CT attenuation correction (CT-AC) scan should be performed during tidal or shallow breathing 1
- For CT systems with six or fewer rings, breath hold in normal expiration may be considered for thorax and upper abdomen scanning 1
- Ultra low-dose CT scans with iterative reconstruction methods can be used to further reduce radiation dose 1
- When using intravenous contrast, equilibrium or venous phase acquisition is preferred; arterial phase CT acquisitions should be avoided 1
Special Protocols
- For dedicated brain imaging:
Important Considerations
Contrast Agent Use
- High intravenous or intestinal concentrations of contrast agent may cause artifacts in reconstructed PET images following CT attenuation correction 1
- When CT data are collected in the equilibrium or venous phase, the impact of intravenous contrast agents on attenuation correction accuracy is generally acceptable 1
- For FDG PET/CT studies without need for advanced quantification, intravenous contrast agents can be used directly for attenuation correction 1, 2
Quality Control
- Images should be reviewed before the patient leaves the department to ensure technical adequacy and to assess any need for additional imaging 1
- Decay correction must be turned on for accurate quantification 1
- All patient information, including height, weight, radiopharmaceutical details, and net activity administered should be carefully entered into the PET/CT system 1
Clinical Applications
- EANM guidelines cover various clinical applications including:
- Detecting and localizing abnormal glucose metabolism in patients with suspected or known malignancies 1
- Staging patients with known malignancies 1
- Monitoring therapy effects on known malignancies 1
- Determining whether residual abnormalities represent tumor or post-treatment changes 1
- Detecting tumor recurrence, especially with elevated tumor markers 1
- Selecting optimal biopsy sites 1
- Guiding radiation therapy planning 1
- Specific guidelines for plasma cell disorders 1
Pitfalls and Caveats
- Deep inspiration chest CT scans should not be used for attenuation correction when PET quantification is required 1
- Side-by-side viewing of PET and CT scans is essential in approximately 42.4% of cases for correct diagnosis 3
- Integrated PET/CT may provide additional information in approximately 6.7% of patients 3
- Radiation safety considerations are important for both patients and staff due to the combination of two radiation-based procedures 4
Following EANM guidelines ensures standardized acquisition protocols, proper patient preparation, and appropriate technical parameters, leading to high-quality PET/CT images with optimal diagnostic value.